7487 Results

People

  1. Brennan
    Brennan
  2. Danishefsky
    Danishefsky
  3. Larson
    Larson
  4. Scheinberg
    Scheinberg
  5. Fuks
    Fuks
  6. Rosen
    Rosen
  7. Hricak
    Hricak
  8. Pasternak
    Pasternak
  9. Sadelain
    Sadelain
  10. Scardino
    Scardino

Groups

  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)
  7. Radiology, Department of (1814)
  8. Hematologic Malignancies Research (1617)
  9. Hematologic Malignancies, Division of (1517)
  10. Center for Molecular Imaging and Biotechnology (1341)
  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (4957)
  2. Meeting Abstract (2007)
  3. Book Section (216)
  4. Conference Paper (122)
  5. Review (79)
  6. Editorial (48)
  7. Book Whole (28)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (957)
  3. Peter Scardino (671)
  4. Michel Sadelain (582)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (36)
  2. 2024 (94)
  3. 2023 (122)
  4. 2022 (150)
  5. 2021 (154)
  6. 2020 (162)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
  2. Blood (379)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (315)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (712)
  2. Elsevier Inc. (693)
  3. Nature Publishing Group (490)
  4. Springer (467)
  5. American Chemical Society (440)
  6. Elsevier Science, Inc. (405)

More Publishers

Results (7487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Prevention of Relapse Following Allogeneic Cell Transplantation for Hematologic Malignancies
    Journal Article

    Alyea, E. P.; DeAngelo, D. J.; Moldrem, J.; Pagel, J. M.; Przepiorka, D.; Sadelain, M.; Young, J. W.; Giralt, S.; Bishop, M.; Riddell, S.
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer
    Journal Article

    Akin, O.; Riedl, C. C.; Ishill, N. M.; Moskowitz, C. S.; Zhang, J.; Hricak, H.
    European Radiology (2010)

    Fulltext@MSK | Save
  • Activation and intrinsic γ-secretase activity of presenilin 1
    Journal Article

    Ahn, K.; Shelton, C. C.; Tian, Y.; Zhang, X.; Gilchrist, M. L.; Sisodia, S. S.; Li, Y. M.
    Proceedings of the National Academy of Sciences of the United States of America (2010)

    Fulltext@MSK | Save
  • Foreword
    Book Section

    Scardino, P. T.
    In Guillonneau, B.; Gill, I. S.; Janetschek, G.; Tuerk, I. A. (Eds.) Laparoscopic Techniques in Uro-Oncology (2009)

    Fulltext@MSK | Save
  • Predicting the long-term risk of prostate cancer-specific mortality after radical prostatectomy
    Meeting Abstract

    Stephenson, A. J.; Klein, E. A.; Kattan, M. W.; Han, M.; Partin, A. W.; Walsh, P. C.; Trock, B. J.; Wood, D. P.; Eggener, S. E.; Eastham, J. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Bioluminescence evaluation of efficacy of oncolytic treatment with Newcastle disease virus (NDV) in malignant pleural mesothelioma
    Meeting Abstract

    Silberhumer, G.; Brader, P.; Wong, J.; Zamarin, D.; Serganova, I.; Blasberg, R.; Palese, P.; Fong, Y.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I/II study of docetaxel and (153)Sm for castrate metastatic prostate cancer (CMPC): Summary of dose-escalation cohorts and first report on the expansion cohort
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Stephenson, R. D.; Hong, C.; Slovin, S. F.; Rathkopf, D.; Solit, D.; Carrasquillo, J.; Larson, S.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Increased expression of androgen receptor (AR) and enzymes involved in androgen synthesis in metastatic prostate cancer: Targets for novel personalized therapies
    Meeting Abstract

    Mitsiades, N.; Schultz, N.; Taylor, B. S.; Hieronymus, H.; Satagopan, J.; Scardino, P. T.; Reuter, V. E.; Sander, C.; Sawyers, C.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Locally advanced prostate cancer: A population-based study of treatment patterns and predictors
    Meeting Abstract

    Lowrance, W.; Eastham, J.; Jacks, L.; Yee, D.; Scardino, P.; Elkin, E.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced stage epithelial ovarian cancer
    Meeting Abstract

    Kolev, V.; Mironov, S.; Mironov, O.; Moskowitz, C.; Ishill, N. M.; Gardner, G. J.; Levine, D. A.; Hricak, H.; Barakat, R. R.; Chi, D. S.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save